cricopharyngeal muscle
Recently Published Documents


TOTAL DOCUMENTS

67
(FIVE YEARS 3)

H-INDEX

17
(FIVE YEARS 0)

Trials ◽  
2021 ◽  
Vol 22 (1) ◽  
Author(s):  
Mengshu Xie ◽  
Zulin Dou ◽  
Guifang Wan ◽  
Peishan Zeng ◽  
Hongmei Wen

Abstract Background Cricopharyngeal dysfunction (CPD) occurs in various neurological disorders, especially stroke. The treatment approaches of CPD include swallowing training, cricopharyngeal dilation, botulinum toxin (BTX) injection, and cricopharyngeal myotomy. BTX injection into the cricopharyngeal muscle is effective and safe for some patients with dysphagia, with a success rate between 43 and 100% (mean = 76%). However, well-designed randomized controlled clinical trials are needed to verify its efficacy and safety for the treatment of CPD. The objective of this study is to explore the efficacy and safety of BTX for neurogenic cricopharyngeal achalasia, when administering an injection into the cricopharyngeal muscle guided by a novel precise positioning method, that combines ultrasound, catheter balloon, and electromyography (BECURE). Methods BECURE is a single-center randomized, placebo controlled, double-blinded, superiority clinical trial. To detect a significant difference between the 2 groups, a sample size of 44 patients is estimated. The intervention is BTX versus placebo, with 1:1 randomization. The randomization sequence from 1 to 44 was generated using the Statistical Package for Social Sciences. The study is divided into two phases. In the first phase, patients will be injected with BTX or the placebo. In the second phase, patients who received a placebo injection and those who did not respond to the first BTX injection will receive an injection of BTX. The primary outcome is the score of the Functional Oral Intake Scale (FOIS). The secondary outcomes are as follows: upper esophageal sphincter (UES) residual pressure, UES resting pressure, duration of UES relaxation, velopharyngeal and laryngopharyngeal peak pressure, UES opening, pharyngeal construction ratio, residue of bolus in the epiglottis valley or piriform sinus, and penetration and aspiration. Discussion Dysphagia is a common complication of stroke. There is lack of high-quality evidence for the efficacy of BTX in treating neurogenic CPD. This study will clarify whether BTX injection into the cricopharyngeal muscle can be effective and safe for patients with stroke and CPD. Trial registration Chinese Clinical Trial Register (ChiCTR1900025562). Registered on September 1, 2019.


Author(s):  
Guofeng Qin ◽  
Jianhuang Zou ◽  
Qiufang Xia ◽  
Jiahao Qin

Dynamic fluoroscopy was used to study swallowing in 84 adult patients. We proposed a method to extract the barium contrast region by improved interframe difference method, and to indirectly determine the position of epigmatous cartilage and cricopharyngeal muscle according to the location of barium meal. The method is easy to understand, and the extraction effect is good, with 85% probability of successful extraction. On the other hand, in order to evaluate the degree of deglutition difficulty, we used calculation to evaluate variables including displacement, duration, residual quantity, etc., except that there were gender differences in variables and external factors, such as illumination, most of the measurement variables had very good reliability. The experimental results showed that the moving target fluid barium was extracted by quantifying dynamic fluorescence deglutition and using gaussian based background subtraction algorithm. We conclude that this approach significantly reduces the time it takes clinicians to examine moving images. This paper describes how to study swallowing disorders by X-ray barium fluoroscopy, explains the application of interframe difference algorithm and background subtraction in deglutiography, and extracts the residual amounts in three locations: oral cavity, epiglottic cartilage and piriform fosse.


2021 ◽  
Vol 422 ◽  
pp. 117327
Author(s):  
Kenichiro Taira ◽  
Madoka Mori-Yoshimura ◽  
Toshiyuki Yamamoto ◽  
Kazuaki Sajima ◽  
Hotake Takizawa ◽  
...  

Medicine ◽  
2020 ◽  
Vol 99 (35) ◽  
pp. e21793
Author(s):  
Yong Seob Jo ◽  
Jung Hyun Cha ◽  
Yong Kyun Kim ◽  
Sun Young Kim ◽  
Hong Sub Lee

2020 ◽  
Vol 41 (11) ◽  
pp. 3067-3073 ◽  
Author(s):  
M. Panebianco ◽  
R. Marchese-Ragona ◽  
S. Masiero ◽  
D. A. Restivo

Abstract Dysphagia is defined as an impairment of this complex and integrated sensorimotor system. It is estimated that 400,000 to 800,000 individuals worldwide develop neurogenic dysphagia per year. Neurogenic dysphagia is typically occurring in patients with neurological disease of different etiologies. A correct and early diagnosis and an appropriate management of dysphagia could be useful for improving patient’s quality of life and may help to prevent or delay death. In the present review, we discuss thoroughly the anatomy and physiology of swallowing and also the pathophysiological mechanisms involved in impaired swallowing, as well as the diagnosis, management, and potential treatments of neurogenic dysphagia. Assessment of neurogenic dysphagia includes medical history, physical exam, and instrumental examinations (fiberoptic endoscopic evaluation of swallowing, videofluoroscopic swallowing study, electromyography). Pharmacological treatment of these problems includes oral anticholinergic drugs. Surgical myotomy of the cricopharyngeal muscle showed an important improvement of oropharyngeal dysphagia associated to upper esophageal sphincter hyperactivity. Chemical myotomy of the upper esophageal sphincter by local injections of botulinum toxin type A into the cricopharyngeal muscle has been proposed as an alternative less invasive and less unsafe than surgical myotomy.


2018 ◽  
Vol 132 (12) ◽  
pp. 1128-1133 ◽  
Author(s):  
K Fujiwara ◽  
K Kawamoto ◽  
K Taira ◽  
T Fukuhara ◽  
S Koyama ◽  
...  

AbstractBackgroundIn endoscopic cricopharyngeal myotomy, surgeons sometimes have concerns about performing an adequate incision with only a narrow intra-cavital view from one direction. In order to overcome these issues, fluoroscopic radiography was used during endoscopic cricopharyngeal myotomy.MethodsPeri-operative fluoroscopic radiography was utilised to check the position of the diverticuloscope, and to confirm the extent of the incision during surgery. A balloon catheter was used to determine whether the cricopharyngeal muscle was sufficiently resected. Blood loss, peri-operative complications, and functional oral swallowing scale and penetration aspiration scale scores were evaluated.ResultsIn 12 out of 15 patients, intra-operative fluoroscopic radiography showed the diverticuloscope positioned in the post-cricoid area, and the cricopharyngeal muscle was raised and the surgery completed without adverse effect. Swallowing functions improved following surgery.ConclusionIntra-operative fluoroscopy might improve endoscopic cricopharyngeal myotomy by allowing surgeons to confirm the extent of resection, and by reducing peri-operative morbidity and complication rates.


2018 ◽  
Vol 144 (10) ◽  
pp. 948
Author(s):  
Bryan J. Stevens ◽  
Ashley M. Geer ◽  
Gregory R. Dion ◽  
Adrienne M. Laury ◽  
Nicholas J. Scalzitti

Sign in / Sign up

Export Citation Format

Share Document